[Male secondary breast cancer after treatment for Hodgkin's disease. Case report and review of the literature].
Hodgkin's disease is now curable in more than 50% of cases, due to its chemo- and radio-sensitivity. However, treatment exposes to a risk of secondary cancer varying from 1 to 10% depending on chemoradiotherapy doses and schedules. We report a case of secondary breast cancer associated with a secondary thyroid cancer observed in a 24-year-old man treated when he was 13 years old by vinblastin and radiation for stage IIA, a Hodgkin's disease.
Boussen
H
H
Institut Salah-Azaiz, boulevard du 9 avril, Bab Saadoun, Tunis, Tunisie. hamouda.boussen@rns.tn
Kochbati
L
L
Besbes
M
M
Dhiab
T
T
Makhlouf
R
R
Jerbi
G
G
Gamoudi
A
A
Benna
F
F
Rahal
K
K
Maalej
M
M
Ben Ayed
F
F
D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects; D018567:Breast Neoplasms, Male / Q000209:etiology*; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D009381:Neoplasms, Radiation-Induced; D016609:Neoplasms, Second Primary; D011878:Radiotherapy / Q000009:adverse effects; D013964:Thyroid Neoplasms / Q000209:etiology*; D014747:Vinblastine / Q000009:adverse effects
D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine
Cancer du sein secondaire chez l'homme après traitement pour maladie de Hodgkin. A propos d'un cas et revue de la littérature.